5 unchanged sentences
4.1 Form of Warrant to Purchase Shares of Series A Preferred Stock (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-4 filed with the SEC on December 6, 2023).
−Removed: 10.1 Stock Purchase Agreeme nt by and between LENZ The rapeutics, Inc.
−Removed: and Ridgeback Capital Inves tment , L.P., dated July 14, 2024.
+Added: 10.1 Stock Purchase Agreement by and between LENZ Therapeutics, Inc.
+Added: and Ridgeback Capital Investment s , L.P., dated July 14, 2024 (inco rporated by reference to Exhibit 10.1 to the Company's Qua r terly Report o n Form 10-Q filed with the SEC on August 14, 2024) .
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
LENZ THERAPEUTICS, INC.
−Removed: August 14, 2024
+Added: November 6, 2024
/s/ Evert Schimmelpennink
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 14, 2024
+Added: November 6, 2024
/s/ Daniel Chevallard
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.